Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response

Versandkostenfrei!
Versandfertig in 6-10 Tagen
150,99 €
inkl. MwSt.
Weitere Ausgaben:
PAYBACK Punkte
75 °P sammeln!
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that tailoring of chemotherapy in cancer - tients might be achieved by molecular analysis of patient tumor DNA. In addition, to reduce the toxicity risk of patients, the tumor DNA information should be in- grated with the available d...